CYTEK BIOSCIENCES, INC. Shareholders' Equity
CYTEK BIOSCIENCES, INC. (CTKB) had Shareholders' Equity of $321.95 million as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-05
- 2026-06-30: Stockholders' Equity Attributable to Parent $321.95M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $327.64M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $341.74M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $378.57M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2026-06-30 | $321.95M 10-Q · filed 2026-08-05 | |
| 2026-03-31 | $327.64M 10-Q · filed 2026-08-05 | |
| 2025-12-31 | $341.74M 10-Q · filed 2026-08-05 | |
| 2025-09-30 | $378.57M 10-Q · filed 2025-11-05 | |
| 2025-06-30 | $377.56M 10-Q · filed 2026-08-05 | |
| 2025-03-31 | $379.62M 10-Q · filed 2026-08-05 | |
| 2024-12-31 | $395.74M 10-Q · filed 2026-08-05 | |
| 2024-09-30 | $385.46M 10-Q · filed 2025-11-05 | |
| 2024-06-30 | $389.12M 10-Q · filed 2025-11-05 | |
| 2024-03-31 | $392.61M 10-Q · filed 2025-11-05 | |
| 2023-12-31 | $393.06M 10-Q · filed 2025-11-05 | |
| 2023-09-30 | $415.52M 10-Q · filed 2024-11-07 | |
| 2023-06-30 | $424.18M 10-Q · filed 2024-11-07 | |
| 2023-03-31 | $423.46M 10-Q · filed 2024-11-07 | |
| 2022-12-31 | $425.55M 10-K · filed 2025-02-28 | |
| 2022-09-30 | $416.51M 10-Q · filed 2023-11-14 | |
| 2022-06-30 | $411.13M 10-Q · filed 2023-11-14 | |
| 2022-03-31 | $407.44M 10-Q · filed 2023-11-14 | |
| 2021-12-31 | $405.38M 10-K · filed 2025-02-28 | |
| 2021-09-30 | $403.19M 10-Q · filed 2022-11-09 | |
| 2021-06-30 | -$10.98M 10-Q · filed 2022-11-09 | |
| 2021-03-31 | -$14.76M 10-Q · filed 2022-11-09 | |
| 2020-12-31 | -$16.03M 10-K · filed 2024-03-13 | |
| 2020-09-30 | -$27.39M 10-Q · filed 2021-11-12 | |
| 2020-06-30 | -$34.30M 10-Q · filed 2021-11-12 | |
| 2020-03-31 | -$42.50M 10-Q · filed 2021-11-12 | |
| 2019-12-31 | $41.70M 10-K · filed 2023-03-01 | -$41.70M 10-Q · filed 2021-09-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B |